USFDA Approves LaNeo MDMA for Clinical Trial Use in the Unit

Approved Study to Examine Tolerability of MDMA in Schizophrenia at UCLA VANCOUVER, British Columbia, June 09, 2023 -- PharmAla Biotech Holdings Inc. , a biotechnology company focused on the... | June 10, 2023

Related Keywords

United Kingdom , Australia , United States , Canada , Denver , Colorado , Vancouver , British Columbia , British , Canadian , David Purcell , Nick Kadysh , Nicholas Kadysh , Harpreet Kaur , Pharmala Biotech Holdings Inc , Neither The Canadian Securities Exchange , Vitura Health , Prescriber Program , Regulation Services Provider , Health Canada , Research At Pharmala Biotech , Drug Administration , Approved Study , Examine Tolerability , Ala Biotech Holdings , Medical Product , Vice President , Authorized Prescriber Program , Joint Venture , Sales Director David Purcell , Psychedelic Science , Canadian Securities Exchange ,